# OnCo record paper-impassion031-nat-med-2025-update (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-impassion031-nat-med-2025-update/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-impassion031-nat-med-2025-update" ;
  schema:name "Peri-operative atezolizumab in early-stage triple-negative breast cancer: final results and ctDNA analyses from the randomized phase 3 IMpassion031 trial"@en ;
  schema:description "Later report from the IMpassion031 trial registered as NCT03197935, in Nature Medicine (2025); its title describes an updated or longer-term analysis."@en ;
  schema:url <https://onco.cc/key-papers/paper-impassion031-nat-med-2025-update/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41591-025-03725-4>, <https://pubmed.ncbi.nlm.nih.gov/40467898/>, <https://europepmc.org/article/MED/40467898>, <https://clinicaltrials.gov/study/NCT03197935> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1038/s41591-025-03725-4> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Mittendorf EA, Assaf ZJ, Harbeck N, et al." ;
  onco:trials <https://onco.cc/trials/impassion031/> ;
  onco:journals <https://onco.cc/journals/nature-medicine/> .